Skip to main content
Top
Published in: Cancer Causes & Control 7/2010

Open Access 01-07-2010 | Original paper

Primary peritoneal and ovarian cancers: an epidemiological comparative analysis

Authors: Delores J. Grant, Patricia G. Moorman, Lucy Akushevich, Rachel T. Palmieri, Rex C. Bentley, Joellen M. Schildkraut

Published in: Cancer Causes & Control | Issue 7/2010

Login to get access

Abstract

We performed case–control analyses using data from the North Carolina Ovarian Cancer Study to determine risk factors that distinguish primary peritoneal cancer (PPC) from epithelial ovarian cancer (EOC). Our risk factor analyses were restricted to invasive serous cancers including 495 EOC cases, 62 PPC cases and 1,086 control women. Logistic regression analyses were used to calculate adjusted odds ratios and 95% confidence intervals for risk factor associations. Although many case–control associations for the invasive serous PPC cases were similar to those of the invasive serous EOC cases, some differences were observed including a twofold increase in risk of invasive serous PPC in women who were ≥35 years at last pregnancy, whereas a decreased risk was observed for invasive serous EOC risk. We could not confirm a previous report of an association between tubal ligation and PPC, a factor consistently associated with a decreased risk of EOC. The difference in the risk factor associations between invasive serous PPC and EOC cancers suggests divergent molecular development of peritoneal and ovarian cancers. A larger study to determine risk factors for invasive serous PPC is warranted.
Literature
1.
go back to reference Swerdlow M (1959) Mesothelioma of the pelvic peritoneum resembling papillary cystadenocarcinoma of the ovary; case report. Am J Obstet Gynecol 77(1):197–200PubMed Swerdlow M (1959) Mesothelioma of the pelvic peritoneum resembling papillary cystadenocarcinoma of the ovary; case report. Am J Obstet Gynecol 77(1):197–200PubMed
2.
go back to reference Bloss JD, Liao SY, Buller RE, Manetta A, Berman ML, McMeekin S et al (1993) Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary. Gynecol Oncol 50(3):347–351CrossRefPubMed Bloss JD, Liao SY, Buller RE, Manetta A, Berman ML, McMeekin S et al (1993) Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary. Gynecol Oncol 50(3):347–351CrossRefPubMed
3.
go back to reference Goodman MT, Shvetsov YB (2009) Rapidly increasing incidence of papillary serous carcinoma of the peritoneum in the United States: fact or artifact? Int J Cancer 124(9):2231–2235CrossRefPubMed Goodman MT, Shvetsov YB (2009) Rapidly increasing incidence of papillary serous carcinoma of the peritoneum in the United States: fact or artifact? Int J Cancer 124(9):2231–2235CrossRefPubMed
4.
go back to reference Goodman MT, Shvetsov YB (2009) Incidence of ovarian, peritoneal, and fallopian tube carcinomas in the United States, 1995–2004. Cancer Epidemiol Biomarkers Prev 18(1):132–139CrossRefPubMed Goodman MT, Shvetsov YB (2009) Incidence of ovarian, peritoneal, and fallopian tube carcinomas in the United States, 1995–2004. Cancer Epidemiol Biomarkers Prev 18(1):132–139CrossRefPubMed
5.
6.
go back to reference Eltabbakh GH, Piver MS, Natarajan N, Mettlin CJ (1998) Epidemiologic differences between women with extraovarian primary peritoneal carcinoma and women with epithelial ovarian cancer. Obstet Gynecol 91(2):254–259CrossRefPubMed Eltabbakh GH, Piver MS, Natarajan N, Mettlin CJ (1998) Epidemiologic differences between women with extraovarian primary peritoneal carcinoma and women with epithelial ovarian cancer. Obstet Gynecol 91(2):254–259CrossRefPubMed
7.
go back to reference Halperin R, Zehavi S, Langer R, Hadas E, Bukovsky I, Schneider D (2001) Primary peritoneal serous papillary carcinoma: a new epidemiologic trend? A matched-case comparison with ovarian serous papillary cancer. Int J Gynecol Cancer 11(5):403–408CrossRefPubMed Halperin R, Zehavi S, Langer R, Hadas E, Bukovsky I, Schneider D (2001) Primary peritoneal serous papillary carcinoma: a new epidemiologic trend? A matched-case comparison with ovarian serous papillary cancer. Int J Gynecol Cancer 11(5):403–408CrossRefPubMed
8.
go back to reference Jordan SJ, Green AC, Whiteman DC, Moore SP, Bain CJ, Gertig DM et al (2008) Serous ovarian, fallopian tube and primary peritoneal cancers: a comparative epidemiological analysis. Int J Cancer 122(7):1598–1603CrossRefPubMed Jordan SJ, Green AC, Whiteman DC, Moore SP, Bain CJ, Gertig DM et al (2008) Serous ovarian, fallopian tube and primary peritoneal cancers: a comparative epidemiological analysis. Int J Cancer 122(7):1598–1603CrossRefPubMed
9.
go back to reference Menczer J, Chetrit A, Barda G, Lubin F, Fishler Y, Altaras M et al (2003) Frequency of BRCA mutations in primary peritoneal carcinoma in Israeli Jewish women. Gynecol Oncol 88(1):58–61CrossRefPubMed Menczer J, Chetrit A, Barda G, Lubin F, Fishler Y, Altaras M et al (2003) Frequency of BRCA mutations in primary peritoneal carcinoma in Israeli Jewish women. Gynecol Oncol 88(1):58–61CrossRefPubMed
10.
go back to reference Casey MJ, Bewtra C (2004) Peritoneal carcinoma in women with genetic susceptibility: implications for Jewish populations. Fam Cancer 3(3–4):265–281CrossRefPubMed Casey MJ, Bewtra C (2004) Peritoneal carcinoma in women with genetic susceptibility: implications for Jewish populations. Fam Cancer 3(3–4):265–281CrossRefPubMed
11.
go back to reference Moorman PG, Schildkraut JM, Calingaert B, Halabi S, Vine MF, Berchuck A (2002) Ovulation and ovarian cancer: a comparison of two methods for calculating lifetime ovulatory cycles (United States). Cancer Causes Control 13(9):807–811CrossRefPubMed Moorman PG, Schildkraut JM, Calingaert B, Halabi S, Vine MF, Berchuck A (2002) Ovulation and ovarian cancer: a comparison of two methods for calculating lifetime ovulatory cycles (United States). Cancer Causes Control 13(9):807–811CrossRefPubMed
12.
go back to reference Schildkraut JM, Calingaert B, Marchbanks PA, Moorman PG, Rodriguez GC (2002) Impact of progestin and estrogen potency in oral contraceptives on ovarian cancer risk. J Natl Cancer Inst 94(1):32–38PubMed Schildkraut JM, Calingaert B, Marchbanks PA, Moorman PG, Rodriguez GC (2002) Impact of progestin and estrogen potency in oral contraceptives on ovarian cancer risk. J Natl Cancer Inst 94(1):32–38PubMed
13.
go back to reference Schildkraut JM, Murphy SK, Palmieri RT, Iversen E, Moorman PG, Huang Z et al (2007) Trinucleotide repeat polymorphisms in the androgen receptor gene and risk of ovarian cancer. Cancer Epidemiol Biomarkers Prev 16(3):473–480CrossRefPubMed Schildkraut JM, Murphy SK, Palmieri RT, Iversen E, Moorman PG, Huang Z et al (2007) Trinucleotide repeat polymorphisms in the androgen receptor gene and risk of ovarian cancer. Cancer Epidemiol Biomarkers Prev 16(3):473–480CrossRefPubMed
14.
go back to reference Eichhorn JH, Robboy SR, Bentley RC, Merino M, Russell P (2009) The Peritoneum. In: Robboy SJ, Mutter GL, Prat J, Bentley RC, Russel P, Anderson MC (eds) Robboy’s pathology of the female reproductive tract, 2nd edn. Churchill Livingstone/Elsevier, Edinburgh, pp 909–945 Eichhorn JH, Robboy SR, Bentley RC, Merino M, Russell P (2009) The Peritoneum. In: Robboy SJ, Mutter GL, Prat J, Bentley RC, Russel P, Anderson MC (eds) Robboy’s pathology of the female reproductive tract, 2nd edn. Churchill Livingstone/Elsevier, Edinburgh, pp 909–945
15.
go back to reference Cooper GS, Schildkraut JM, Whittemore AS, Marchbanks PA (1999) Pregnancy recency and risk of ovarian cancer. Cancer Causes Control 10(5):397–402CrossRefPubMed Cooper GS, Schildkraut JM, Whittemore AS, Marchbanks PA (1999) Pregnancy recency and risk of ovarian cancer. Cancer Causes Control 10(5):397–402CrossRefPubMed
16.
go back to reference Whiteman DC, Siskind V, Purdie DM, Green AC (2003) Timing of pregnancy and the risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 12(1):42–46PubMed Whiteman DC, Siskind V, Purdie DM, Green AC (2003) Timing of pregnancy and the risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 12(1):42–46PubMed
17.
18.
Metadata
Title
Primary peritoneal and ovarian cancers: an epidemiological comparative analysis
Authors
Delores J. Grant
Patricia G. Moorman
Lucy Akushevich
Rachel T. Palmieri
Rex C. Bentley
Joellen M. Schildkraut
Publication date
01-07-2010
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 7/2010
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-010-9525-6

Other articles of this Issue 7/2010

Cancer Causes & Control 7/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine